Fagan Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,092
| Closed | -$242K | – | 136 |
|
|
2025
Q2 | $242K | Hold |
3,092
| – | – | 0.04% | 117 |
|
|
2025
Q1 | $224K | Sell |
3,092
-800
| -21% | -$57.3K | 0.04% | 119 |
|
|
2024
Q4 | $288K | Sell |
3,892
-580
| -13% | -$40.6K | 0.05% | 120 |
|
|
2024
Q3 | $295K | Hold |
4,472
| – | – | 0.05% | 115 |
|
|
2024
Q2 | $413K | Sell |
4,472
-205
| -4% | -$18.2K | 0.07% | 97 |
|
|
2024
Q1 | $447K | Hold |
4,677
| – | – | 0.08% | 98 |
|
|
2023
Q4 | $357K | Hold |
4,677
| – | – | 0.08% | 92 |
|
|
2023
Q3 | $324K | Sell |
4,677
-48
| -1% | -$3.86K | 0.08% | 93 |
|
|
2023
Q2 | $446K | Hold |
4,725
| – | – | 0.11% | 84 |
|
|
2023
Q1 | $391K | Buy |
4,725
+48
| +1% | +$3.77K | 0.1% | 93 |
|
|
2022
Q4 | $349K | Hold |
4,677
| – | – | 0.09% | 99 |
|
|
2022
Q3 | $386K | Hold |
4,677
| – | – | 0.11% | 92 |
|
|
2022
Q2 | $445K | Hold |
4,677
| – | – | 0.12% | 89 |
|
|
2022
Q1 | $551K | Hold |
4,677
| – | – | 0.11% | 96 |
|
|
2021
Q4 | $606K | Hold |
4,677
| – | – | 0.12% | 93 |
|
|
2021
Q3 | $529K | Sell |
4,677
-80
| -2% | -$9.13K | 0.12% | 94 |
|
|
2021
Q2 | $493K | Buy |
4,757
+1,256
| +36% | +$118K | 0.11% | 100 |
|
|
2021
Q1 | $293K | Sell |
3,501
-34
| -1% | -$2.87K | 0.07% | 110 |
|
|
2020
Q4 | $322K | Sell |
3,535
-100
| -3% | -$8.29K | 0.08% | 101 |
|
|
2020
Q3 | $290K | Sell |
3,635
-100
| -3% | -$7.8K | 0.08% | 96 |
|
|
2020
Q2 | $258K | Hold |
3,735
| – | – | 0.08% | 96 |
|
|
2020
Q1 | $235K | Sell |
3,735
-210
| -5% | -$15.1K | 0.09% | 94 |
|
|
2019
Q4 | $307K | Hold |
3,945
| – | – | 0.1% | 103 |
|
|
2019
Q3 | $289K | Hold |
3,945
| – | – | 0.11% | 101 |
|
|
2019
Q2 | $243K | Hold |
3,945
| – | – | 0.1% | 106 |
|
|
2019
Q1 | $252K | Hold |
3,945
| – | – | 0.11% | 103 |
|
|
2018
Q4 | $201K | Hold |
3,945
| – | – | 0.1% | 105 |
|
|
2018
Q3 | $229K | Sell |
3,945
-192
| -5% | -$9.39K | 0.09% | 110 |
|
|
2018
Q2 | $201K | Buy |
+4,137
| New | +$193K | 0.09% | 111 |
|